2.Primary Retroperitoneal Mucinous Cystadenocarcinoma: A Case Report and Review of the Literature.
Sun Ah LEE ; Sung Hwa BAE ; Hun Mo RYOO ; Hyun Young JUNG ; Saet Byul JANG ; Yoon Seup KUM
The Korean Journal of Internal Medicine 2007;22(4):287-291
Primary retroperitoneal mucinous cystadenocarcinoma is a rare tumor. Only about 30 such cases have been reported in the worldwide literature, and a few Korean cases have been reported. The pathogenesis is not clear, and coelomic metaplasia of the retroperitoneal mesothelium has gained wide support. There is no consensus on the appropriate treatment, but surgical exploration is needed for the diagnosis and treatment, and adjuvant chemotherapy may be recommended following complete surgical excision. The long-term prognosis has not been established. We report here on a 32-year-old woman who was diagnosed as having a retroperitoneal mucinous cystadenocarcinoma with mural nodules of sarcomatoid change. Tumor excision and adjuvant chemotherapy were done and the patient is doing well without any evidence of recurrence at 42 months postoperatively.
Adult
;
Cystadenocarcinoma, Mucinous/*diagnosis/pathology/surgery
;
Female
;
Humans
;
Retroperitoneal Neoplasms/*diagnosis/pathology/surgery
3.Immunophenotypings of malignant epithelial mesothelioma and their roles in the differential diagnosis.
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(2):112-115
To investigate the immunophenotypings of malignant epithelial mesothelioma (MEM), and to seek the valuable markers in distinguishing peritoneal MEM from peritoneal metastatic ovarian adenocarcinoma (OA) and colorectal adenocarcinoma (CA), immunohistochemical SP method was used to detect expressions of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 in paraffin-embedded tissues of 18 cases of MEM, 20 OA and 20 CA. The results showed that there was a significant difference in the expressions of E-cadherin, CA19-9 and MOC-31 between MEM and OA group (P<0.05). Similarly, the difference in the expression of HBME-1, E-cadherin, CA19-9, MOC-31 and CK7 between MEM and CA groups is significant (P<0.05). These results indicate that HBME-1 could be used as a positive marker in distinguishing MEM from CA. E-cadherin, CA19-9 and MOC-31 are considered to be useful negative markers in diagnostic distinction between MEM and metastatic adenocarcinomas, including OA and CA. CK7 is the best positive marker in distinguishing MEM from CA, but this marker appears to be valueless in discriminating MEM from OA.
Adenocarcinoma
;
diagnosis
;
pathology
;
Colorectal Neoplasms
;
complications
;
diagnosis
;
pathology
;
Cystadenocarcinoma, Mucinous
;
diagnosis
;
pathology
;
Cystadenocarcinoma, Serous
;
diagnosis
;
pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Immunophenotyping
;
Male
;
Mesothelioma
;
diagnosis
;
etiology
;
pathology
;
Ovarian Neoplasms
;
complications
;
diagnosis
;
pathology
;
Peritoneal Neoplasms
;
diagnosis
;
etiology
;
pathology
4.Ovarian needle aspiration in the diagnosis and management of ovarian masses.
Kimberly NAGAMINE ; Jordan KONDO ; Ricky KANESHIRO ; Pamela TAUCHI-NISHI ; Keith TERADA
Journal of Gynecologic Oncology 2017;28(4):e40-
OBJECTIVE: Ovarian needle aspiration and biopsy (ONAB) may be employed for pretreatment diagnosis of ovarian malignancies or intraoperatively to facilitate removal of ovarian masses. However, there is reluctance to utilize this procedure due to potential cyst rupture or seeding of malignant cells. The objective of this study was to examine the efficacy of ONAB over a 13-year period at our institution. METHODS: Between 2000 and 2013, all ONAB specimens were identified from the Queen's Medical Center Pathology Department database. All cytologic specimens were reviewed and correlated with histopathologic findings. A retrospective chart review was conducted to retrieve data on clinical course and treatment. RESULTS: This study identified 144 cases of ovarian masses sampled by aspiration or needle biopsy between 2000 and 2013. Ninety-two (64%) cases had corresponding histopathology, 84 (91%) of which were obtained concomitantly. On histology, 12 (13%) cases were malignant and 80 (87%) benign. Three false negative cases were noted; 2 serous borderline tumors and 1 mucinous cystadenocarcinoma. These were sampling errors; no diagnostic tumor cells were present in the aspirates. Sensitivity and specificity of ONAB in the detection of malignancy were 75% and 100%, respectively. The positive and negative predictive values were 100% and 96%, respectively. CONCLUSION: ONAB represents a valuable tool in the diagnosis of malignancy and treatment of ovarian masses. In our study, it was highly specific, with excellent positive and negative predictive value.
Biopsy
;
Biopsy, Needle
;
Cystadenocarcinoma, Mucinous
;
Diagnosis*
;
Needles*
;
Ovarian Neoplasms
;
Pathology
;
Retrospective Studies
;
Rupture
;
Selection Bias
;
Sensitivity and Specificity
5.Mucoceles and mucocele-like lesions of breast.
Chinese Journal of Pathology 2009;38(9):633-636
Adenocarcinoma, Mucinous
;
pathology
;
Breast
;
pathology
;
Breast Diseases
;
pathology
;
Breast Neoplasms
;
pathology
;
Carcinoma, Papillary
;
pathology
;
Carcinoma, Signet Ring Cell
;
pathology
;
Cystadenocarcinoma, Mucinous
;
pathology
;
Diagnosis, Differential
;
Female
;
Fibroadenoma
;
pathology
;
Fibrosarcoma
;
pathology
;
Humans
;
Mucocele
;
pathology
;
Myxosarcoma
;
pathology
6.Clinicopathologic Review of 41 Cases of Pancreatic Mucinous Cystic Neoplasms.
Jong Cheol KIM ; Myung Hwan KIM ; Tae Yoon LEE ; Ji Young KIM ; Jeung Hye HAN ; Soo Jung PARK ; Sang Soo LEE ; Dong Wan SEO ; Sei Jin JANG ; Sung Koo LEE
The Korean Journal of Gastroenterology 2008;51(1):34-39
BACKGROUND/AIMS: Intraductal papillary mucinous neoplasms (IPMN) and mucinous cystic neoplasms are included in mucin-producing pancreatic tumors. The reports about IPMN are not uncommon but those about the mucinous cystic neoplasms are relatively few. The aims of this study were to define the natural history of resected mucinous cystic neoplasms of the pancreas and to identify the findings which suggest malignancy. METHODS: The authors retrospectively evaluated the clinical outcomes of 41 patients with mucinous cystic neoplasms who were surgically resected at Asan Medical Center between 1995 and 2004. RESULTS: Women (n=33) were more frequently affected than men (n=8). Thirty three patients (80.6%) had adenoma, 1 (2.4%) borderline malignancy, 1 (2.4%) carcinoma in situ, and 6 (14.6%) invasive mucinous cystadenocarcinoma. The most frequent symptom was abdominal pain (39%). About half of the enrolled patients were asymptomatic. Unilocular type (79%) was more frequent than the multilocular type (21%) on gross morphology. The tumor size of invasive mucinous cystic neopolasms was larger than that of non-invasive mucinous cystic neoplalsms (p=0.01). Abdominal pain was more frequent in invasive mucinous cystic neoplasms (p=0.026). On gross morphology, mural nodules were detected in 4 of 6 patients with invasive mucinous cystic neoplasms. However, they were not detected in any patients with non-invasive mucinous cystic neoplasms. Recurrence developed in none of the 35 patients with non-invasive mucinous cystic neoplasms, however 2 of the 6 patients with invasive mucinous cystic neoplasms died within 5 years. CONCLUSIONS: Clinical predictors of invasive mucinous cystic neoplasms are suggested to be tumor size and abdominal pain. The prognosis of the non-invasive mucinous cystic neoplasms is excellent when curative resection is performed.
Adenocarcinoma, Mucinous/*diagnosis/pathology/surgery
;
Adult
;
Aged
;
Carcinoma, Pancreatic Ductal/diagnosis/pathology/surgery
;
Cystadenocarcinoma, Mucinous/diagnosis/pathology
;
Diagnosis, Differential
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Invasiveness
;
Pancreatic Neoplasms/*diagnosis/pathology/surgery
;
Retrospective Studies
;
Survival Analysis
7.Clinicopathologic analysis of 92 cases of pancreatic cystic neoplasm.
Yuan JI ; Xiong-zeng ZHU ; Wen-hui LOU ; Dong-qing WANG ; Da-yong JIN ; Meng-su ZENG ; Hai-ying ZENG
Chinese Journal of Pathology 2007;36(3):160-165
OBJECTIVETo study the clinicopathologic and immunohistochemical features of cystic neoplasms of the pancreas.
METHODSNinety-two cases of cystic neoplasm of pancreas were retrieved from the Department archival file during the period from 1999 to 2005. Histologic features were studied and the tumors were typed according to WHO classification. Immunohistochemistry was also carried out using paraffin-embedded tissues.
RESULTSThe age of patients ranged from 16 to 80 years. The patients included 33 males and 59 females. The tumors varied from 2 cm to 21 cm in diameter. They consisted of intraductal papillary mucinous neoplasm (36/92), serous cystic neoplasm (18/92), solid pseudopapillary tumor (18/92), mucinous cystic neoplasm (14/92), cystic pancreatic ductal adenocarcinoma (4/92) and cystic pancreatic endocrine neoplasm (2/92). Immunohistochemical study revealed variable staining patterns, with frequent overlaps between different tumor types. In general, serous cystic neoplasm expressed MUC1, while mucinous cystic neoplasm was positive for MUC-5AC, intraductal papillary mucinous neoplasm for MUC-2 and cystic pancreatic ductal adenocarcinoma for MUC-1. On the other hand, solid pseudopapillary tumor expressed alpha-antitrypsin, alpha-antichymotrypsin, vimentin and progesterone receptor.
CONCLUSIONSAccurate diagnosis of pancreatic cystic neoplasms requires correlation of clinical findings, radiologic examination, histologic features and immunostaining results. Pathologic distinction is important because of different prognostic significance. Two-thirds of pancreatic cystic neoplasms are premalignant or malignant and warrant surgical resection, whereas the remaining one-third (including pseudocyst and serous cystadenoma) are benign and can be treated conservatively.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Papillary ; metabolism ; pathology ; Cystadenocarcinoma, Mucinous ; metabolism ; pathology ; Cystadenocarcinoma, Serous ; metabolism ; pathology ; Cystadenoma, Mucinous ; metabolism ; pathology ; Cystadenoma, Serous ; metabolism ; pathology ; Diagnosis, Differential ; Female ; Humans ; Male ; Middle Aged ; Mucin 5AC ; metabolism ; Mucin-1 ; metabolism ; Neoplasms, Cystic, Mucinous, and Serous ; metabolism ; pathology ; Pancreatic Neoplasms ; metabolism ; pathology ; Young Adult
8.Application of immunohistochemistry in differential diagnosis of endometrial carcinoma.
Chinese Journal of Pathology 2012;41(11):784-788
Adenocarcinoma, Clear Cell
;
diagnosis
;
metabolism
;
pathology
;
Adenocarcinoma, Mucinous
;
diagnosis
;
metabolism
;
pathology
;
Biomarkers, Tumor
;
metabolism
;
Carcinoma, Endometrioid
;
diagnosis
;
metabolism
;
pathology
;
Cystadenocarcinoma, Serous
;
diagnosis
;
metabolism
;
pathology
;
Diagnosis, Differential
;
Endometrial Neoplasms
;
diagnosis
;
metabolism
;
pathology
;
Female
;
Humans
;
Immunohistochemistry
;
Uterine Cervical Neoplasms
;
diagnosis
;
metabolism
;
pathology
9.Characterization and diagnostic accuracy of serous cystadenomas and mucinous neoplasms of the pancreas with multi-slice helical computed tomography.
Dong YUAN ; Wei YU ; Xiao-Bo REN ; Wei-Dong PAN ; Li-Hua ZHANG
Acta Academiae Medicinae Sinicae 2007;29(2):232-237
OBJECTIVETo evaluate the feasibility of using multi-slice helical computed tomography (MS-CT) to accurately distinguish serous cystadenomas from mucinous cystadenomas or cystadenocarcinomas of the pancreas and to determine their radiographic appearances that can be applied for differentiative diagnosis.
METHODSWe performed a single-blind retrospective analysis of CT images of 30 patients with pathologically proven primary cystic pancreatic neoplasms (12 cases of serous cystadenomas, 14 cases of mucinous cystadenomas, and 4 cases of mucinous cystadenocarcinomas) to reach a diagnosis of either serous cystadenoma or mucinous cystic tumor. CT features such as tumor location, septations, presence of calcification, features of cystic wall, papillary excrescences, and size of the largest cyst were recorded. Statistical analysis was performed to evaluate the efficacy of certain CT findings in the differentiation of serous cystadenomas and mucinous neoplasms.
RESULTSTotally 9 (75.0%) serous cystadenomas and 16 (88.9%) mucinous tumors were correctly diagnosed. Three serous cystadenomas were misdiagnosed as mucinous cystadenomas, while 2 mucinous neoplasms were misdiagnosed as serous cystadenomas. And 9 (75.0%) serous cystadenomas were located at the pancreatic head and neck areas, while 12 (66.7%) mucinous neoplasms were located at the pancreatic body and tail areas (P < 0.05). The presence of calcification, especially central calcification, had statistical significance in differentiating serous cystadenoma from mucinous neoplasms (P < 0.05). The size of the largest cyst over 2 cm was positive associated with mucinous neoplasms (P < 0.05).
CONCLUSIONCT characteristics between serous cystadenomas and mucinous neoplasms of the pancreas have distinct difference, which validates the values of CT in differentiating these tumors. However, atypical CT appearances may compromise its diagnostic accuracy.
Cystadenocarcinoma, Mucinous ; diagnostic imaging ; pathology ; Cystadenoma, Mucinous ; diagnostic imaging ; pathology ; Cystadenoma, Serous ; diagnostic imaging ; pathology ; Diagnosis, Differential ; Diagnostic Errors ; Humans ; Pancreatic Neoplasms ; diagnostic imaging ; pathology ; Retrospective Studies ; Single-Blind Method ; Tomography, Spiral Computed
10.Differentiation between malignant and benign ovarian tumors by magnetic resonance imaging.
Min CHEN ; Wen-Chao WANG ; Cheng ZHOU ; Ni-Na ZHOU ; Kui CAI ; Zheng-Han YANG ; Wei-Feng ZHAO ; Sa-Ying LI ; Guo-Zhen LI
Chinese Medical Sciences Journal 2006;21(4):270-275
OBJECTIVETo determine the magnetic resonance (MR) imaging findings of an ovarian mass which are most predictive of malignancy and assess the value of intravenous gadolinium administration in the characterization of an ovarian mass.
METHODSTotally 74 consecutive patients with a clinically or sonographically indeterminate adnexal mass underwent MR imaging, of whom 59 had subsequent surgical resection of 70 adnexal masses. These 59 patients formed the study population. MR imaging studies were prospectively and independently reviewed by a senior and a junior radiologist. The senior radiologist also reevaluated the studies in a blind fashion after a minimum 6 months interval. The sensitivity, specificity, positive predictive value, and negative predictive value of contrast-enhanced and unenhanced MR imaging were evaluated.
RESULTSThe most predictive MR imaging findings for malignancy were presence of vegetations in a cystic lesion and presence of necrosis in a solid lesion. The odds ratio was even higher when the ancillary finding of peritoneal metastasis or ascites was present. Contrast media contributed significantly to lesion characterization. Total 70 ovarian masses were detected by contrast-enhanced MR imaging including 37 malignant ovarian masses and 33 benign ovarian masses with 87% (61/70) accuracy, 86% (32/37) sensitivity, 88% (29/33) specificity, 89% (32/36) positive predictive value, and 85% (29/34) negative predictive value, whereas 70 ovarian masses were detected by unenhanced MR imaging with 74% (52/70) accuracy, 73% (27/37) sensitivity, 76% (25/33) specificity, 77% (27/35) positive predictive value, and 71% (25/35) negative predictive value. There were significant differences in accuracy (P < 0.01), sensitivity (P < 0.01), specificity (P < 0.01) between contrast-enhanced and unenhanced MR imaging.
CONCLUSIONContrast-enhanced MR imaging is highly accurate in detection and characterization of complex adnexal masses.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cystadenocarcinoma, Serous ; diagnosis ; pathology ; Cystadenoma, Mucinous ; diagnosis ; pathology ; Female ; Humans ; Image Enhancement ; Magnetic Resonance Imaging ; methods ; Middle Aged ; Ovarian Neoplasms ; diagnosis ; pathology ; Sensitivity and Specificity ; Teratoma ; diagnosis ; pathology